Eranga Siriweera

Dr. Eranga Siriweera

InfinityPath

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SBSudarma Bogahawaththa
Sudarma Bogahawaththa
Suranga KodithuwakkuSuranga Kodithuwakku
Suranga Kodithuwakku
KWKavindra Wijesundera
Kavindra Wijesundera
ESEranga Siriweera
Eranga Siriweera
LJLalith Jayasinghe
Lalith Jayasinghe
MWMissaka Wijayagunawardane
Missaka Wijayagunawardane
Chronic liver inflammation has become a major global health concern. In the absence of clinical surrogate markers to diagnose inflammatory liver disease, the intervention with effective drugs in modern medicine tends to be late. In Sri Lanka, traditional medical practitioners prescribe herbal preparations from Osbeckia octandra for the prevention and treatment of liver disorders. To test the efficacy of such treatments, we have administered thioacetamide (TAA) to male Wistar rats to induce chronic liver damage (disease control; DC) and examined how various leaf extracts: crude leaf suspension (CLS), boiled leaf extract (BLE), sonicated leaf extract (SLE), methanol leaf extract (MLE) and hexane leaf extract (HLE) of O. octandra ameliorate TAA-induced liver disease. The CLS, BLE and SLE treatments in cirrhotic rats significantly attenuated disease-related changes, such as liver weight and hepato-enzymes. The mRNA levels of Tnf-α were significantly decreased by 3.6, 10 and 3.9 times in CLS, BLE and SLE compared to DC. The same treatments resulted in significantly lower (19.5, 4.2 and 2.4 times) α-Sma levels compared to DC. In addition, Tgf-β1 and Vegf-R2 mRNA expressions were significantly lower with the treatments. Moreover, BLE expressed a strong anti-angiogenic effect. We conclude that CLS, BLE and SLE from O. octandra have potent hepatic anti-fibrotic effects in TAA-induced liver cirrhosis.

5 January 2015 in International Journal of Celiac Disease
Verified
Journal Article
Open access
PDF file
ESEranga Siriweera
Eranga Siriweera
ZQZhengyan Qi
Zhengyan Qi
JYJim. L. C. Yong
Jim. L. C. Yong
The gold standard for diagnosis of Celiac disease (CD) is histological evidence of a small intestinal biopsy together with positive serology. Modified Marsh classification utilizes the histological parameter of intraepithelial lymphocyte (IEL) count in the diagnosis of CD. The reported upper limit of normal IEL in the duodenum varies from 20-40 per 100 epithelial cells (EC). The objectives of the study are to determine the normal upper limit of IEL in the duodenum and assess the diagnostic accuracy of existing criteria of IEL counts to diagnose CD. A retrospective analysis of histopathological records of duodenal biopsies reported as normal (control group, n=38) and consistent with CD (n=37) formed the basis of the study. IEL were counted in an uninterrupted length of surface epithelium and villous tips from formalin fixed, paraffin embedded, Haematoxylin and Eosin stained biopsies under the light microscope (X400 magnification). In the control group the mean IEL/100EC was 3.81(upper limit of normal = 7.78) and the mean IEL/villous tip was 0.96 (upper limit of normal = 3.5). In CD the mean IEL/100EC and mean IEL/villous tip were 20.93 and 6.83 respectively. The upper limit of normal IEL/100EC, mean IEL/100EC in CD and the villous tip IEL count in both the control and CD groups were considerably lower than those reported in other studies. The ethnicity, country of origin and environmental factors may be partly responsible for this observation. If high cut off values of IEL/100EC is taken to diagnose CD many cases may be under diagnosed, particularly when the upper limit of the normal IEL count is lower for that population and region, highlighting the importance of a multidisciplinary approach in the diagnosis of CD.

31 December 2019 in Sri Lanka Journal of Medicine
Verified
Journal Article
Open access
PDF file
SMSubhashini Muhamdiram
Subhashini Muhamdiram
Suranga KodithuwakkuSuranga Kodithuwakku
Suranga Kodithuwakku
TKThusitha Kumara Karunarathna
Thusitha Kumara Karunarathna
ESEranga Siriweera
Eranga Siriweera
TWThilini Kumari Weerasinghe
Thilini Kumari Weerasinghe
CRChathura Jayanath Ratnayake
Chathura Jayanath Ratnayake
Background Cervical cancer (CC) is the second leading type of cancer among females in Sri Lanka. Unawareness about risk factors, prevention methods, socio-cultural and economic factors hinder women from participating in screening programmes offered currently. This study intended to assess the factors associated with uptake of cervical cancer screening programmes by women, among a cohort of gynecology clinic attendees. Conclusions Low uptake of cervical cancer screening in the study group was mainly caused by lack of awareness about the disease, risk factors and preventative measures. Mass media and health care workers can play vital roles in raising awareness on cervical cancer screening and prevention among the public.